We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00979745
Recruitment Status : Completed
First Posted : September 18, 2009
Last Update Posted : August 4, 2011
Sponsor:
Information provided by:
Clinuvel Pharmaceuticals Limited